Molecular genetic analysis of TGF β1 in breast cancer

Journal of Experimental and Clinical Cancer Research

Volumn 16, Issue 1, 1997, Pages 57-63

  Cardillo, M R ^a   Yap, E ^b   Castagna, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Defence Medical Research Institute   (Singapore)

Author keywords

breast cancer; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 0030963564     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Delvenne C.G., Winkler-Gol R.A., Piccart M.J., Hustin P.J., Michaux D., Leclercq G., Nogaret J.M., Autier Ph.: Expression of c-erbB2, TGF-β1 and S2 genes in primary human breast cancers. Eur. J. Cancer 28 (2/3): 700-705, 1992.
2. Levine J.H., Moses H.L., Gold L.I., Nanney L.B.: Spatial and temporal patterns of immunoreactive transforming growth factor, β1, β2 and β3 during excisional wound repair. Am. J. Pathol. 143 (2): 368-380, 1993.
3. Sporn M.B., Roberts A.B.: Transforming growth factor-β: Recent progress and new challenges. J. Cell. Biology 119 (3): 1017-1021, 1992.
4. Massague J.: The transforming growth factor-beta family. Annu Rev. Cell. Biol. 6: 597-641, 1990.
5. Moses H.L., Yang E.Y., Pietenpol J.A.: TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 63: 245-247, 1990.
6. Streuli C.H., Schmidhause C., Kobrin M., Bissel M., Derynck R.: Extracellular matrix regulates expression of the TGF-β1 gene. J. Cell. Biology 120 (1): 253-260, 1993.
7. Roberts A.B., Sportn M.B.: Physiological actions and clinical applications of transforming growth factor β (TGF-β). Growth Factors 8: 1-9, 1993.
8. Knabbe C., Lippman M.E., Wakefield L.M., et al.: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48: 417-428, 1987.
9. Cardillo M.R., Yap E.P.H.. Molecular genetic analysis of TGF β1 in ovarian neoplasia (submitted for publication in Cancer detection and Prevention).
10. Derynck R., Rhee L., Chen E.Y., Tilburg A.V.: Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Research 15 (7): 3188-3189, 1987.
11. Yap E.P.H., and McGee J. O'D.: Nonisotopic detection of PCR products by ethidium bromide staining. Trends Genet 8: 49, 1992.
12. Yap E.P.H., and McGEE J. O'D.: Nucleic Acids Res 20: 145, 1992.
13. Sambrock J., Fritsch E.F., Maniatis T. (eds.): Molecular Cloning-A laboratory Manual, ed. 2 Cold Spring Harbor 1989.
14. Derynck .R, Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V.: Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701-705, 1985.
15. Cardillo M.R., Walker R.M., Yap E.P.H.: Expression of cathepsin D mRNA in ovarian neoplasia: demonstration by non isotopic in situ hybridisation and immunohistochemistry. J. Clin. Cancer Res. 14 (2): 1-9, 1995.
16. Cardillo M.R.: Localization of transforming growth factor β1 mRNA in colorectal neoplasia: correlation with antigen expression of gelatinase and tissue inhibitors of metalloproteinase. J. Exp. Clin. Cancer Res. 14 (3): 1-10, 1995.
17. Kohn E.: Aging issues in invasion and metastasis. Cancer 71: 552-557, 1993.
18. Gorsh S.M., Memoli V.A., Stukel T.A., Gold L.I., Arrick B.A.: Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Research 52: 6949-6952, 1992.
19. Dublin E.A., Barnes D.M., Wang D.Y., King R.J.B., Levison D.A.: TGF alpha and TGF beta expression in mammary carcinoma. J. Pathology 170: 15-22, 1993.
20. Mizukami Y., Nonomura A., Yanada T., et al.: Immunohistochemical demonstration of growth factors TGF alpha, TGF-beta, IFG-I and neu oncogene product in benign and malignant breast tissues. Anticancer Res. 10: 1115-1126, 1990.
21. Daniel C.W., Robinson S.D.: Regulation of mammary growth and function by TGF-β1. Molecular Reproduction & Development 32 (2): 145-151, 1992.
22. Walker R.A., Dearing S.J.: Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur. J. Cancer 28 (23): 641-644, 1992.
23. McCune B.K., Mullin B.R., Flanders K.C., Jaffurs W.J., Mullen L.T., Sportn M.B.: Localization of transforming growth factor-β1 isotypes in lesions of the human breast. Human Pathol. 23: 13-20, 1992.
24. Travers M.T., Barrett-Lee P.J., Berger U., et al.: Growth factor expression in normal benign and malignant breast tissue. Br. Med. J. 296: 1621-1624, 1988.
25. Matrisian L.M., Bowden G.T., Krieg P., Furstenberger G., Briand J.P., Leroy P., Breathnach R.: The mRNA coding for secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA 83: 9413-9417, 1986.
26. Shetler-Steverson W.G.: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9: 289-304, 1990.
27. Samuel S.K., Hurta R.A.R., Kondaiah P., Rhalil N., Turley E.A., Wright J.A., Greenbergg A.H.: Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1 (Ser 223, 225). Embo. J. 11: 1599-1605, 1992.
28. Dalai B.I., Keown P.A., Greenberg A.M.: Immunocytochemical localization of secreted transforming growth factor-β1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathology 143 (2): 381-389, 1993.
29. Boyd F.T., Massague J.: Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53 kDa membrane receptor. J. Biol. Chem. 264: 2272 2278, 1989.